Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
about
HLA-DR alpha 2 mediates negative signalling via binding to Tirc7 leading to anti-inflammatory and apoptotic effects in lymphocytes in vitro and in vivoExotoxins of Staphylococcus aureusGram-positive bacterial superantigen outside-in signaling causes toxic shock syndromeCrystal structure of staphylococcal enterotoxin I (SEI) in complex with a human major histocompatibility complex class II moleculeCross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expressionTypes of inter-atomic interactions at the MHC-peptide interface: identifying commonality from accumulated dataStaphylococcal Superantigens Spark Host-Mediated Danger SignalsFar East Scarlet-Like Fever: A Review of the Epidemiology, Symptomatology, and Role of Superantigenic Toxin: Yersinia pseudotuberculosis-Derived Mitogen AStaphylococcal manipulation of host immune responsesThe staphylococcal enterotoxin (SE) family: SEB and siblingsStaphylococcal superantigens in colonization and diseaseStructural features of a zinc binding site in the superantigen strepococcal pyrogenic exotoxin A (SpeA1): Implications for MHC class II recognitionCrystal structure of a superantigen bound to MHC class II displays zinc and peptide dependenceStructural and functional role of threonine 112 in a superantigen Staphylococcus aureus enterotoxin BStructural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIαZinc-mediated dimerization and its effect on activity and conformation of staphylococcal enterotoxin type CThe Three-dimensional structure of a superantigen-like protein, SET3, from a pathogenicity island of the Staphylococcus aureus genomeZinc Induces Dimerization of the Class II Major Histocompatibility Complex Molecule That Leads to Cooperative Binding to a SuperantigenIdentification of a secondary zinc-binding site in staphylococcal enterotoxin C2. Implications for superantigen recognitionCrystal Structure of Mycoplasma arthritidis Mitogen Complexed with HLA-DR1 Reveals a Novel Superantigen Fold and a Dimerized Superantigen-MHC ComplexStructural basis of T-cell specificity and activation by the bacterial superantigen TSST-1A Novel Loop Domain in Superantigens Extends their T Cell Receptor Recognition SiteCrystal Structure of Staphylococcal Enterotoxin G (SEG) in Complex with a Mouse T-cell Receptor ChainStructural basis for the neutralization and specificity of Staphylococcal enterotoxin B against its MHC Class II binding siteCrystal structure of the superantigen staphylococcal enterotoxin type AThe Co-crystal structure of staphylococcal enterotoxin type A with Zn2+ at 2.7 A resolution. Implications for major histocompatibility complex class II bindingCrystal structure of the streptococcal superantigen SPE-C: dimerization and zinc binding suggest a novel mode of interaction with MHC class II moleculesThe Immune System of HIV-Exposed Uninfected InfantsIdentification of residues in the V domain of CD80 (B7-1) implicated in functional interactions with CD28 and CTLA4Structural features of the invariant chain fragment CLIP controlling rapid release from HLA-DR molecules and inhibition of peptide bindingInvariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1Virus-encoded superantigensThe role of common protective alleles HLA-DRB1*13 among systemic autoimmune diseases.Overview of protein folds in the immune system.Uptake and intracellular trafficking of superantigens in dendritic cells.Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis.Isolation of HLA-DR1.(staphylococcal enterotoxin A)2 trimers in solution.Understanding the mechanism of action of bacterial superantigens from a decade of research.Protective effect of the HLA-DRB1*13:02 allele in Japanese rheumatoid arthritis patients.
P2860
Q21562298-2EE65976-F4B4-4D51-94A0-33535AA877F7Q24550718-D3AE3115-5C5A-4778-889D-2EF9AE1ED441Q24607551-534581B4-78FD-4702-B8E9-CD02CC9841A7Q24648495-4589E93E-22C9-43BE-AA2B-E6942392877AQ24678746-E92FB0C8-90C7-4D79-8F1E-8035669D21B0Q24793027-51FE70C2-25F9-4BB1-B05D-F385E2311160Q26766421-C5A6B5C7-EC6A-4B5D-96F8-BE0941FA7635Q26773071-9F8E444E-44F3-4FCC-9242-1F3E8DC65222Q26798461-6C3DA261-65C4-49C5-AA50-1DFAA04794A4Q26830220-CF94A028-2FC8-446B-8B6C-4DF37AF81D79Q26995577-A60AD536-4FB6-4359-A680-CA8629CA00BEQ27631880-EEE37F27-3334-4B60-97EA-E9FD12307B1BQ27632891-C16818EB-6926-46DC-AE7F-57E3F7B9F93CQ27636147-9CE550F6-A7F0-4354-8C11-4BE9C5823A3CQ27637839-E43A76F5-7BF4-4CAB-8473-92EA91F23803Q27638736-3930A42E-EE64-421E-9F16-0CC47078A020Q27639245-A9E6C353-8C6E-489E-A1CD-A1CDD6AA19D6Q27640743-CCF02B11-0732-4AE5-A6B5-F3C9A1F97B46Q27642358-9B29FF2B-82C1-4AE0-A6C7-BAF5EC5049CCQ27643132-DA35FED3-70C8-4995-BCBE-23D1CBED5B7BQ27643710-41D61DE0-47B6-4F99-9A4F-AB5C59F735F9Q27645551-E6D7B3E7-9F3C-47A4-ACD5-9B4FD69880D7Q27665660-EB5B0B9A-23D8-4320-A385-B2D043677F8AQ27681324-7F31B3C7-110C-40D3-B6C0-69F75E0D6E7AQ27729789-E806FB4B-B347-4974-A63A-EEB395628576Q27734048-D6962645-F2E3-49B0-B50B-22AC08275B7FQ27741449-3C928EC2-8E85-4474-9EB2-4E7C3BB8D13EQ28069872-5090AF2E-E24E-4ACF-AC62-41F6C72A6D49Q28114978-4F071D94-6465-421B-B148-CA8F2F835EF5Q28612873-98BD2921-966C-4933-8048-0AAA243AC609Q28776057-06BCC50D-9E3D-4673-9667-FCF084DAC14AQ28776748-E82DCA54-3F23-4534-9C96-BC48FFFC38C1Q30241539-C9951440-6C7B-47DF-9BCD-78E0E64B8CC5Q30369011-5EE7B83A-06A6-488D-A104-9E072C8246EDQ31120808-A51AC1F4-6746-4D0A-AC5A-A7E4567F886AQ33575103-A38F11A1-D16B-43B5-9535-8CF138E4D6DDQ33622670-E38FCFE6-551D-4C0B-8F9E-93CCF2DCC915Q33651985-4A1DD6FB-E74B-4D3D-8617-A99E885BBA54Q33683420-652AA72D-1651-453C-82E1-FCA8DAF9475BQ33728049-D97207DF-F0A2-4FD3-A1E1-B8A19DA76610
P2860
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen
description
1994 nî lūn-bûn
@nan
1994 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Three-dimensional structure of ...... le complexed with superantigen
@ast
Three-dimensional structure of ...... le complexed with superantigen
@en
Three-dimensional structure of ...... le complexed with superantigen
@nl
type
label
Three-dimensional structure of ...... le complexed with superantigen
@ast
Three-dimensional structure of ...... le complexed with superantigen
@en
Three-dimensional structure of ...... le complexed with superantigen
@nl
prefLabel
Three-dimensional structure of ...... le complexed with superantigen
@ast
Three-dimensional structure of ...... le complexed with superantigen
@en
Three-dimensional structure of ...... le complexed with superantigen
@nl
P2093
P3181
P356
P1433
P1476
Three-dimensional structure of ...... le complexed with superantigen
@en
P2093
C Stauffacher
T S Jardetzky
P2888
P3181
P356
10.1038/368711A0
P407
P577
1994-04-21T00:00:00Z
P5875
P6179
1021670380